0 false false false false false false false true false false true false false false false false false No description of principal activity 2025-04-17 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 16395252 2025-04-17 2026-04-30 16395252 2026-04-30 16395252 2025-04-16 16395252 bus:Director1 2025-04-17 2026-04-30 16395252 core:ShareCapital 2026-04-30 16395252 bus:SmallEntities 2025-04-17 2026-04-30 16395252 bus:AuditExemptWithAccountantsReport 2025-04-17 2026-04-30 16395252 bus:SmallCompaniesRegimeForAccounts 2025-04-17 2026-04-30 16395252 bus:PrivateLimitedCompanyLtd 2025-04-17 2026-04-30 16395252 bus:FullAccounts 2025-04-17 2026-04-30
COMPANY REGISTRATION NUMBER: 16395252
CURE CLINICS SPECIALIST SERVICES LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
30 April 2026
CURE CLINICS SPECIALIST SERVICES LTD
STATEMENT OF FINANCIAL POSITION
30 April 2026
30 Apr 26
Note
£
£
CURRENT ASSETS
Debtors
4
100
-----
NET CURRENT ASSETS
100
-----
TOTAL ASSETS LESS CURRENT LIABILITIES
100
-----
CURE CLINICS SPECIALIST SERVICES LTD
STATEMENT OF FINANCIAL POSITION (continued)
30 April 2026
30 Apr 26
Note
£
£
CAPITAL AND RESERVES
Called up share capital
100
-----
SHAREHOLDERS FUNDS
100
-----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the period and has not made either a profit or loss.
For the period ending 30th April 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 9 July 2026 , and are signed on behalf of the board by:
Mr M Ball
Director
Company registration number: 16395252
CURE CLINICS SPECIALIST SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS
PERIOD FROM 17th APRIL 2025 TO 30th APRIL 2026
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 10 Cable Court, Pittman Way, Preston, PR2 9YW, United Kingdom.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. ACCOUNTING POLICIES
BASIS OF PREPARATION
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
INCOME STATEMENT
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current period.
4. DEBTORS
30 Apr 26
£
Other debtors
100
-----